ALX Oncology Holdings (ALXO) ROE US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| ROE, % | ? | -23.0% | -46.9% | -84.8% | -118.7% | -391.4% | -391.4% | |
| Changes by years, y/y, % | -62pp | -24pp | -38pp | -34pp | -273pp | |||
ALX Oncology Holdings. ROE, %
ALX Oncology Holdings. ROE, changes, pp
ALX Oncology Holdings (ALXO) ROE US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| ROE, % | ? | -118.7% | -147.3% | -181.0% | -241.1% | -391.4% | -391.4% | |
| Changes by years, y/y, % | -34pp | -46pp | -73pp | -131pp | -273pp | |||
| Changes by quarters, q/q, % | -8pp | -29pp | -34pp | -60pp | -150pp | |||